Astellas Broadens Commitment to Clinical Trial Data Transparency

February 4, 2015

Applied Clinical Trials

Astellas Pharma Inc. (Tokyo: 4503, "Astellas") announced today that the company will now make trial data available through www.clinicalstudydatarequest.com,

Astellas Pharma announced that the company will now make trial data available through www.clinicalstudydatarequest.com, an independent Web site that enables researchers to request and access clinical trial data after approval of a research proposal by an independent review panel. This site was developed to enable researchers to request data from clinical studies and perform further research that could help advance medical science or improve patient care. In addition, Astellas also recently revised and expanded its Global Policy on Clinical Trial Data Disclosure, which details the company's principles regarding registration of clinical trials, posting and publication of trial results and scientific community access to trial data. The policy is available at www.astellas.com/en/corporate/disclosure/clinicalstudies.html.

Read the full release here.

Related Content:

News